Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
Clinical trial NCT00892112 · COMPLETED
Trial details
- NCT number
- NCT00892112
- Sponsor
- Prothya Biosolutions
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2018-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.